These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


380 related items for PubMed ID: 8857999

  • 1. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.
    Ono Y, Tamiya T, Ichikawa T, Kunishio K, Matsumoto K, Furuta T, Ohmoto T, Ueki K, Louis DN.
    J Neuropathol Exp Neurol; 1996 Oct; 55(10):1026-31. PubMed ID: 8857999
    [Abstract] [Full Text] [Related]

  • 2. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
    Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN.
    Cancer Res; 1996 Jan 01; 56(1):150-3. PubMed ID: 8548755
    [Abstract] [Full Text] [Related]

  • 3. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
    Tsuzuki T, Tsunoda S, Sakaki T, Konishi N, Hiasa Y, Nakamura M.
    Cancer; 1996 Jul 15; 78(2):287-93. PubMed ID: 8674005
    [Abstract] [Full Text] [Related]

  • 4. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
    Dreyling MH, Bullinger L, Ott G, Stilgenbauer S, Müller-Hermelink HK, Bentz M, Hiddemann W, Döhner H.
    Cancer Res; 1997 Oct 15; 57(20):4608-14. PubMed ID: 9377576
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic and prognostic significance of cyclin A expression in low-grade astrocytomas: comparison with astrogliosis and high-grade tumours.
    Hara A, Saegusa M, Ichinoe M, Okayasu I.
    J Clin Pathol; 2008 Mar 15; 61(3):287-92. PubMed ID: 18156430
    [Abstract] [Full Text] [Related]

  • 6. Loss of P16INK4 expression is frequent in high grade gliomas.
    Nishikawa R, Furnari FB, Lin H, Arap W, Berger MS, Cavenee WK, Su Huang HJ.
    Cancer Res; 1995 May 01; 55(9):1941-5. PubMed ID: 7728764
    [Abstract] [Full Text] [Related]

  • 7. Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas.
    Huang L, Goodrow TL, Zhang SY, Klein-Szanto AJ, Chang H, Ruggeri BA.
    Cancer Res; 1996 Mar 01; 56(5):1137-41. PubMed ID: 8640773
    [Abstract] [Full Text] [Related]

  • 8. Abnormalities of p16, p15 and CDK4 genes in recurrent malignant astrocytomas.
    Saxena A, Robertson JT, Ali IU.
    Oncogene; 1996 Aug 01; 13(3):661-4. PubMed ID: 8760309
    [Abstract] [Full Text] [Related]

  • 9. CDKN2/p16 inactivation and p16 immunohistochemistry in astrocytic gliomas.
    Piva R, Cavalla P, Bortolotto S, Cordera S, Grosso R, Richiardi P, Dutto A, Schiffer D.
    Int J Oncol; 1998 Jan 01; 12(1):55-8. PubMed ID: 9454886
    [Abstract] [Full Text] [Related]

  • 10. Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas.
    Walker DG, Duan W, Popovic EA, Kaye AH, Tomlinson FH, Lavin M.
    Cancer Res; 1995 Jan 01; 55(1):20-3. PubMed ID: 7805033
    [Abstract] [Full Text] [Related]

  • 11. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.
    Nielsen GP, Burns KL, Rosenberg AE, Louis DN.
    Am J Pathol; 1998 Jul 01; 153(1):159-63. PubMed ID: 9665476
    [Abstract] [Full Text] [Related]

  • 12. Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization.
    Balázs M, Carroll P, Kerschmann R, Sauter G, Waldman FM.
    Genes Chromosomes Cancer; 1997 Jun 01; 19(2):84-9. PubMed ID: 9171998
    [Abstract] [Full Text] [Related]

  • 13. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A, Gaddipati JP, Moul JW, Srivastava S.
    J Urol; 1998 May 01; 159(5):1725-30. PubMed ID: 9554401
    [Abstract] [Full Text] [Related]

  • 14. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
    Lang FF, Miller DC, Pisharody S, Koslow M, Newcomb EW.
    Oncogene; 1994 Mar 01; 9(3):949-54. PubMed ID: 8108140
    [Abstract] [Full Text] [Related]

  • 15. MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme.
    Moulton T, Samara G, Chung WY, Yuan L, Desai R, Sisti M, Bruce J, Tycko B.
    Am J Pathol; 1995 Mar 01; 146(3):613-9. PubMed ID: 7887443
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.